These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37963212)

  • 1. Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies.
    Hagos YB; Lecat CSY; Patel D; Mikolajczak A; Castillo SP; Lyon EJ; Foster K; Tran TA; Lee LSH; Rodriguez-Justo M; Yong KL; Yuan Y
    Cancer Res; 2024 Feb; 84(3):493-508. PubMed ID: 37963212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patients.
    Ninkovic S; Purton LE; Harrison SJ; Quach H
    Haematologica; 2024 May; 109(5):1487-1500. PubMed ID: 37855027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
    Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
    Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the immunoperoxidase technic to bone marrow trephine biopsies in the classification of patients with monoclonal gammopathies.
    Peterson LC; Brown BA; Crosson JT; Mladenovic J
    Am J Clin Pathol; 1986 Jun; 85(6):688-93. PubMed ID: 3085474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
    Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
    Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
    Charles KS; Winfield DA; Angel C; Goepel J
    Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.
    Bailur JK; McCachren SS; Doxie DB; Shrestha M; Pendleton K; Nooka AK; Neparidze N; Parker TL; Bar N; Kaufman JL; Hofmeister CC; Boise LH; Lonial S; Kemp ML; Dhodapkar KM; Dhodapkar MV
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.
    El-Masri BM; Leka B; Mustapha F; Gundesen MT; Hinge M; Lund T; Andersen TL; Diaz-delCastillo M; Jafari A
    Oncotarget; 2024 Jan; 15():20-26. PubMed ID: 38227739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis.
    Gámez B; Edwards CM
    Curr Osteoporos Rep; 2018 Dec; 16(6):635-641. PubMed ID: 30229522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology.
    Hillengass J; Bäuerle T; Bartl R; Andrulis M; McClanahan F; Laun FB; Zechmann CM; Shah R; Wagner-Gund B; Simon D; Heiss C; Neben K; Ho AD; Schlemmer HP; Goldschmidt H; Delorme S; Stieltjes B
    Br J Haematol; 2011 Jun; 153(6):721-8. PubMed ID: 21517815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
    Ndacayisaba LJ; Rappard KE; Shishido SN; Ruiz Velasco C; Matsumoto N; Navarez R; Tang G; Lin P; Setayesh SM; Naghdloo A; Hsu CJ; Maney C; Symer D; Bethel K; Kelly K; Merchant A; Orlowski R; Hicks J; Mason J; Manasanch EE; Kuhn P
    Curr Oncol; 2022 Apr; 29(5):2954-2972. PubMed ID: 35621632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Myeloma and the Immune Microenvironment.
    Kawano Y; Roccaro AM; Ghobrial IM; Azzi J
    Curr Cancer Drug Targets; 2017; 17(9):806-818. PubMed ID: 28201978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
    Costa F; Vescovini R; Marchica V; Storti P; Notarfranchi L; Dalla Palma B; Toscani D; Burroughs-Garcia J; Catarozzo MT; Sammarelli G; Giuliani N
    Front Immunol; 2020; 11():613007. PubMed ID: 33488620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
    Sidiqi MH; Aljama M; Kumar SK; Jevremovic D; Buadi FK; Warsame R; Lacy MQ; Dingli D; Gonsalves WI; Fonder AL; Hobbs MA; Hwa YL; Kapoor P; Kourelis T; Leung N; Muchtar E; Lust JA; Kyle RA; Go RS; Rajkumar VS; Gertz MA; Dispenzieri A
    Blood Cancer J; 2020 May; 10(5):52. PubMed ID: 32376870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Microenvironment for Treating Multiple Myeloma.
    Neumeister P; Schulz E; Pansy K; Szmyra M; Deutsch AJ
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.
    Foglietta M; Castella B; Mariani S; Coscia M; Godio L; Ferracini R; Ruggeri M; Muccio V; Omedé P; Palumbo A; Boccadoro M; Massaia M
    Haematologica; 2014 Oct; 99(10):1605-10. PubMed ID: 24972771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
    Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of focal lesions in the clot section with negative bone marrow aspirate and trephine biopsy-A series of 5 cases.
    Bhatti V; Kakkar N
    Indian J Pathol Microbiol; 2023; 66(3):584-586. PubMed ID: 37530344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.